GlaxoSmithKline delivers strong 1Q growth, confirms July demerger of Haleon
Pharmaceutical giant GlaxoSmithKline (GSK) delivered strong first quarter growth with revenues up 32% to £9.7 billion and adjusted earnings per share up 43% to 32.8p in constant currencies.The company reaffirmed 2022 guidance for...
27 April 2022